As direct mutation evidence suggests, somatic mutations in chromatin‐regulating genes MLL1 ̃3 and ARID1A in pancreatic cancer patients are associated with improved survival.38 In addition, this association may also hold true in CRC and STAD. This evidence concerns the gene ARID1A and pancreatic neoplasm.